OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction
NCT: NCT07713069 · NOT_YET_RECRUITING
Brief Summary
Cataract is the leading cause of blindness worldwide, yet 5-20% of patients fail to achieve satisfactory visual recovery after surgery. Current methods for predicting postoperative visual acuity lack accuracy, particularly in patients with co-morbid fundus diseases. The OCT-PRO model, developed by our team, uses artificial intelligence (AI) to integrate optical coherence tomography (OCT) images and clinical data to forecast surgical outcomes. This multi-center, randomized, single-blind trial aims to compare the predictive accuracy of OCT-PRO-assisted predictions versus standard clinician predictions. A total of 534 participants will be randomized 1:1 to either the experimental group (OCT-PRO-assisted prediction) or the control group (routine care). The primary outcome is the mean absolute error (MAE) between predicted and actual postoperative best-corrected visual acuity (BCVA). Secondary outcomes include patient satisfaction, informed decision-making scores, and clinician acceptance of the AI tool. This study will provide high-level evidence on the clinical utility of AI in optimizing cataract surgical decision-making and patient communication.
Frequently Asked Questions
What is OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction?
OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction is a clinical trial registered under NCT07713069. Current status: NOT_YET_RECRUITING.
What is the status of NCT07713069?
The current status of NCT07713069 (OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction) is: NOT_YET_RECRUITING.
When did OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction start?
OCT-PRO Model vs. Clinicians: Cataract Surgery Outcome Prediction started on 2026-07-20.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.